These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 32593155)
1. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer. Luo C; Chen J; Chen L Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155 [TBL] [Abstract][Full Text] [Related]
2. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
3. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
4. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer. Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden. Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519 [No Abstract] [Full Text] [Related]
7. Gene expression and immune infiltration in melanoma patients with different mutation burden. Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680 [TBL] [Abstract][Full Text] [Related]
8. Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer. Wu Z; Wang M; Liu Q; Liu Y; Zhu K; Chen L; Guo H; Li Y; Shi B Int J Med Sci; 2020; 17(1):89-96. PubMed ID: 31929742 [TBL] [Abstract][Full Text] [Related]
9. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment. Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843 [TBL] [Abstract][Full Text] [Related]
10. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203 [No Abstract] [Full Text] [Related]
11. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma. Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908 [TBL] [Abstract][Full Text] [Related]
12. Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer. Zhang Z; Yu Y; Zhang P; Ma G; Zhang M; Liang Y; Jiao W; Niu H BMC Cancer; 2021 Apr; 21(1):458. PubMed ID: 33894748 [TBL] [Abstract][Full Text] [Related]
13. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis. Cai Y; Wang X; Wang N; Wu J; Ma L; Xie X; Zhang H; Dang C; Kang H; Zhang S; Zhou Z Life Sci; 2021 Jul; 277():119505. PubMed ID: 33872662 [TBL] [Abstract][Full Text] [Related]
14. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer. Lv J; Zhu Y; Ji A; Zhang Q; Liao G Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32239176 [TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database. Liu J; Xu W; Li S; Sun R; Cheng W Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439 [No Abstract] [Full Text] [Related]
16. Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma. Chen J; Zhang L; Lu CH; Xu CZ Comb Chem High Throughput Screen; 2024; 27(14):2110-2124. PubMed ID: 38213141 [TBL] [Abstract][Full Text] [Related]
17. Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors. Wang ZM; Xu QR; Kaul D; Ismail M; Badakhshi H Thorac Cancer; 2021 Jul; 12(13):1995-2006. PubMed ID: 34033229 [TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Tumor Mutation Burden and Immune Cell Infiltration in Thymic Epithelial Tumors. Du H; Xie S; Guo W; Zhang W; Che J; Zhu L; Hang J Ann Clin Lab Sci; 2021 Jan; 51(1):44-54. PubMed ID: 33653780 [TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden. Lin J; Lin Y; Huang Z; Li X Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma. Luo Y; Chen Q; Lin J Math Biosci Eng; 2022 May; 19(7):7055-7075. PubMed ID: 35730296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]